Similar articles for PMID: 23750452

Year	Number of Results
1991	2
1993	2
1994	1
1995	4
1996	5
1998	4
1999	2
2000	4
2001	3
2002	3
2003	3
2004	4
2005	2
2006	4
2007	3
2008	3
2009	8
2010	5
2011	5
2012	6
2013	15
2014	8
2015	2
2016	4
2017	6
2018	4
2019	3
2020	9
2021	12
2022	21
2023	7
2024	0

1

An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.

Manuel SL, Sehgal M, Khan ZK, Goedert JJ, Betts MR, Jain P. Manuel SL, et al. AIDS Res Hum Retroviruses. 2013 Sep;29(9):1273-85. doi: 10.1089/aid.2013.0054. Epub 2013 Jul 19. AIDS Res Hum Retroviruses. 2013. PMID: 23750452 Free PMC article.

2

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Enose-Akahata Y, Abrams A, Johnson KR, Maloney EM, Jacobson S. Enose-Akahata Y, et al. Blood. 2012 Mar 22;119(12):2829-36. doi: 10.1182/blood-2011-11-390807. Epub 2012 Feb 7. Blood. 2012. PMID: 22318200 Free PMC article.

3

Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.

Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N. Kozako T, et al. Hum Immunol. 2011 Nov;72(11):1001-6. doi: 10.1016/j.humimm.2011.07.308. Epub 2011 Aug 2. Hum Immunol. 2011. PMID: 21851845

4

Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.

Manuel SL, Sehgal M, Connolly J, Makedonas G, Khan ZK, Gardner J, Betts MR, Jain P. Manuel SL, et al. J Clin Immunol. 2013 Oct;33(7):1223-39. doi: 10.1007/s10875-013-9918-x. Epub 2013 Jul 26. J Clin Immunol. 2013. PMID: 23888327 Free PMC article.

5

IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Best I, López G, Verdonck K, González E, Tipismana M, Gotuzzo E, Vanham G, Clark D. Best I, et al. Immunology. 2009 Sep;128(1 Suppl):e777-86. doi: 10.1111/j.1365-2567.2009.03082.x. Epub 2009 Feb 17. Immunology. 2009. PMID: 19740339 Free PMC article.

6

The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.

Bidkhori HR, Hedayati-Moghaddam MR, Mosavat A, Valizadeh N, Tadayon M, Ahmadi Ghezeldasht S, Rafatpanah H, Rezaee SA. Bidkhori HR, et al. J Neurovirol. 2020 Jun;26(3):338-346. doi: 10.1007/s13365-020-00832-5. Epub 2020 Apr 8. J Neurovirol. 2020. PMID: 32270468

7

HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.

Benencio P, Fraile Gonzalez SA, Ducasa N, Page K, Berini CA, Biglione MM. Benencio P, et al. Retrovirology. 2020 Sep 3;17(1):29. doi: 10.1186/s12977-020-00536-y. Retrovirology. 2020. PMID: 32883310 Free PMC article.

8

Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.

Nose H, Saito M, Usuku K, Sabouri AH, Matsuzaki T, Kubota R, Eiraku N, Furukawa Y, Izumo S, Arimura K, Osame M. Nose H, et al. J Neurovirol. 2006 Jun;12(3):171-7. doi: 10.1080/13550280600827336. J Neurovirol. 2006. PMID: 16877298

9

Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.

Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. Kubota R, et al. AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1705-9. doi: 10.1089/08892220050193182. AIDS Res Hum Retroviruses. 2000. PMID: 11080814

10

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.

Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR. Jeffery KJ, et al. J Immunol. 2000 Dec 15;165(12):7278-84. doi: 10.4049/jimmunol.165.12.7278. J Immunol. 2000. PMID: 11120862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year